SlideShare a Scribd company logo
1 of 25
Download to read offline
INSULIN: STRUCTURE, SYNTHESIS AND ANALYTICAL
METHODS
Prepared By :- SHADY ALHUSSAYNI
SBCB (R1)
OUTLINE:
• Insulin structure, synthesis and regulation.
• Biochemical and physiological effects of Insulin.
• Review of analytical methods.
• Associated diseases at variety level of insulin.
INTRODUCTION:
-It is a peptide hormone produced by beta cells of Langerhans of pancreas.
-It is the main anabolic hormone of the body.
-It regulates the metabolism of carbohydrates, fats and protein by promoting the
absorption of glucose from the blood into fat in liver and skeletal muscle cells.
INTRODUCTION:
-It was the first hormone to be isolated, purified & synthesized.
-First hormone to be sequenced.
-First hormone to be produced by recombinant DNA technology.
STRUCTURE:
• Human Insulin contain 51 aminoacids, arranged in TWO Polypeptide chains.
• Chain A = 21 AA
• Chain B = 30 AA
• Two Interchain Disulfide bridge = A7-B7 & A20-B19.
• Intrachain Disulfide link in chain A = 6-11.
STRUCTURE:
SYNTHESIS AND REGULATION:
• The preproinsulin precursor of insulin is encoded by the INS gene.
• Gene is located on Chr 11.
• Produced from β-cell of Langerhans of pancreas.
• Synthesis involve two precursors :-
1. Preproinsulin = 108AA
2. Proinsulin = 86 AA
SYNTHESIS AND REGULATION:
• These are serially degraded to form the active hormone Insulin and
Connecting peptide (C-Peptide).
• C-peptide has no biological activity, however its estimation in plasma
serves as the useful index for endogenous production of insulin.
• In β-cells, Insulin combines with Zinc to form a complex & stored in
granules.
REGULATION OF INSULIN SECRETION
• About 40-50Units secreted daily by Human pancreas.
• Normal value is = 20-30 μU/ml.
BIOCHEMICAL AND PHYSIOLOGICAL EFFECTS:
(1) Carbohydrate metabolism:
(a) It increases the rate of transport of glucose across the cell membrane
in adipose tissue and muscle.
(b) it increases the rate of glycolysis in muscle and adipose tissue.
(c) it stimulates the rate of glycogen synthesis in several tissues. It also decreases the rate of
glycogen breakdown in muscle and liver.
(d) it inhibits the rate of gluconeogenesis in the liver.
(2) Lipid Metabolism:
(a) It decreases the rate of lipolysis in adipose tissue and hence lowers the plasma fatty
acid level
(b) it stimulates fatty acid and triacylglycerol synthesis in tissues.
(c) it increases the rate of very-low-density lipoprotein formation in the liver.
(d) it increases the uptake of triglyceride from the blood into adipose tissue and muscle.
(e) it decreases the rate of fatty acid oxidation in muscle and liver
(f) it increases the rate of cholesterol synthesis in liver.
(3) Protein Metabolism:
(a) It increases the rate of transport of some amino acids into tissues,
(b) it increases the rate of protein synthesis in muscle, adipose tissue, liver, and other
tissues.
(c) it decreases the rate of protein degradation in muscle (and perhaps other tissues)
(d) it decreases the rate of urea formation.
Review of Analytical Methods.
• Nowadays, immunoassays and chromatographic assays are the primary methods that
have been developed for insulin analysis.
• Generally, immunoassays including:
• Enzyme-linked immunosorbent assay (ELISA).
• Chemiluminescence immunoassay (CLIA).
• Radioimmunoassay (RIA).
((good selectivity towards insulin with less interferences))
Review of Analytical Methods.
• Chromatographic assays including:
• High performance liquid chromatography coupled with ultraviolet detection (HPLC-UV).
• Liquid chromatography with tandem mass spectrometry (LC-MS/MS).
((are highly sensitive and capable of simultaneous detection of insulin)).
VARIATION IN THE LEVEL OF INSULIN SECRETION AND
ASSOCIATED DISEASES
• High level of insulin:
1-Acromegaly
2-Cushing syndrome
3-Fructose or galactose intolerance
4-Insulinomas – a tumor of beta cells producing excess insulin.
5-Obesity
6-Insulin resistance, such as appears in type 2 diabetes and metabolic syndrome
VARIATION INTHE LEVEL OF INSULIN SECRETION AND
ASSOCIATED DISEASES
• Low level of insulin:
1-Diabetes
2-Hypopituitarism
3-Pancreatic diseases such as chronic pancreatitis (including cystic fibrosis) and pancreatic
cancer.
DISEASE ASSOCIATEDWITH HIGH INSULIN LEVEL
• Insulinoma :- Insulinoma is a tumor found in the pancreas that continues to
produce insulin even when your blood sugar drops too low.
• High blood insulin levels cause low blood sugar levels called Hypoglycemia.
• Hypoglycemia may be mild, leading to symptoms such as anxiety and hunger or it
can be severe, leading to seizures, coma and even death.
SYMPTOMS OF INSULINOMA
• Anxiety
• Weight Gain (patient can
become excessively obese)
• Behavior Changes
• CloudedVision
• Confusion
• Hunger
• Loss of Consciousness
• Rapid Heart Rate
• Sweating
TESTS FOR INSULINOMA DIAGNOSIS
• After fasting, blood tested for:
• C-peptide level.
• Glucose level.
• Insulin level.
• Drugs that cause the pancreas to release insulin.
• CT or MRI scan of the abdomen may be done to look for a tumor in the pancreas.
DISEASE ASSOCIATEDWITH LOW INSULIN LEVEL
• Diabetes mellitus (DM):-
• Commonly known as diabetes, is a group of metabolic disorders characterized by high blood
sugar levels over a prolonged period. Diabetes is due to either the pancreas not producing
enough insulin, or the cells of the body not responding properly to the insulin produced.
• Type 1 diabetes results from the pancreas's failure to produce enough insulin due to loss of
beta cells.This form was previously referred to as "insulin-dependent diabetes mellitus"
• Type 2 diabetes begins with insulin resistance, a condition in which cells fail to respond to
insulin properly.As the disease progresses, a lack of insulin may also develop.This form was
previously referred to as "non-insulin-dependent diabetes mellitus"
SYMPTOMS
OF DIABETES
DIAGNOSIS OF DIABETES
• Analysis for the Diagnosis & Monitoring of the Diabetes status:-
• Blood Glucose (Fasting & PPBS).
• OGTT (Oral Glucose tolerance test).
• Glycated Hb (HbA1c).
• Urine Glucose.
• Insulin, C-Peptide.
INSULIN RESISTANCE (IR)
• Insulin resistance (IR) is a pathological condition in which cells fail to
respond normally to the insulin.
• Tests For insulin resistance:-
• Hyperinsulinemic euglycemic clamp (Gold std).
• Modified insulin suppression test.
• HOMA (homeostatic model assessment), QUICKI (quantitative insulin
sensitivity check index).
THANK YOU

More Related Content

Similar to SHADY-Insulin-Hormone.pdf

Regulation of blood sugar
Regulation of blood sugarRegulation of blood sugar
Regulation of blood sugardrswati4
 
Diabetes mellitus overview and treatments
Diabetes mellitus overview and treatmentsDiabetes mellitus overview and treatments
Diabetes mellitus overview and treatmentsFarzana Sultana
 
Anti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptxAnti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptxManu1418
 
Anti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptxAnti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptxManu1418
 
Diabetes Mellitus MBC 120.pptx
Diabetes Mellitus MBC 120.pptxDiabetes Mellitus MBC 120.pptx
Diabetes Mellitus MBC 120.pptxchishimbalouis1
 
Diabetes mellitus cme dr.saranya
Diabetes mellitus cme  dr.saranyaDiabetes mellitus cme  dr.saranya
Diabetes mellitus cme dr.saranyaDr.Sabari Nathan
 
diabetes Mellitus type 1simple introduction
diabetes Mellitus type 1simple introductiondiabetes Mellitus type 1simple introduction
diabetes Mellitus type 1simple introductionAmany Elshamy
 
Assessment Of Pancreatic Hormones In Diabetes Mellitus & Non-diabetes Mellitu...
Assessment Of Pancreatic Hormones In Diabetes Mellitus & Non-diabetes Mellitu...Assessment Of Pancreatic Hormones In Diabetes Mellitus & Non-diabetes Mellitu...
Assessment Of Pancreatic Hormones In Diabetes Mellitus & Non-diabetes Mellitu...Rahul Gautam
 
Diabetes Mellitus(Past,Present and Future)
Diabetes Mellitus(Past,Present and Future)Diabetes Mellitus(Past,Present and Future)
Diabetes Mellitus(Past,Present and Future)Vikas Reddy
 
Anti diabetic drugs
Anti diabetic drugsAnti diabetic drugs
Anti diabetic drugsDevang Sheth
 
Pharmacology of antidiabetic drugs
Pharmacology of antidiabetic drugsPharmacology of antidiabetic drugs
Pharmacology of antidiabetic drugsSaleem Cology
 
Endocrine main [Autosaved].pptx for students
Endocrine main [Autosaved].pptx for studentsEndocrine main [Autosaved].pptx for students
Endocrine main [Autosaved].pptx for studentsEstibelMengist
 
Anti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptxAnti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptxManu1418
 

Similar to SHADY-Insulin-Hormone.pdf (20)

Regulation of blood sugar
Regulation of blood sugarRegulation of blood sugar
Regulation of blood sugar
 
Diabetes mellitus overview and treatments
Diabetes mellitus overview and treatmentsDiabetes mellitus overview and treatments
Diabetes mellitus overview and treatments
 
Anti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptxAnti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptx
 
Insulin Hormone.pdf
Insulin Hormone.pdfInsulin Hormone.pdf
Insulin Hormone.pdf
 
Diabties
DiabtiesDiabties
Diabties
 
Anti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptxAnti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptx
 
Shk biochemical tests
Shk   biochemical testsShk   biochemical tests
Shk biochemical tests
 
Diabetes Mellitus MBC 120.pptx
Diabetes Mellitus MBC 120.pptxDiabetes Mellitus MBC 120.pptx
Diabetes Mellitus MBC 120.pptx
 
Diabetes mellitus cme dr.saranya
Diabetes mellitus cme  dr.saranyaDiabetes mellitus cme  dr.saranya
Diabetes mellitus cme dr.saranya
 
Endocrine system
Endocrine systemEndocrine system
Endocrine system
 
diabetes Mellitus type 1simple introduction
diabetes Mellitus type 1simple introductiondiabetes Mellitus type 1simple introduction
diabetes Mellitus type 1simple introduction
 
Assessment Of Pancreatic Hormones In Diabetes Mellitus & Non-diabetes Mellitu...
Assessment Of Pancreatic Hormones In Diabetes Mellitus & Non-diabetes Mellitu...Assessment Of Pancreatic Hormones In Diabetes Mellitus & Non-diabetes Mellitu...
Assessment Of Pancreatic Hormones In Diabetes Mellitus & Non-diabetes Mellitu...
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
Diabetes Mellitus(Past,Present and Future)
Diabetes Mellitus(Past,Present and Future)Diabetes Mellitus(Past,Present and Future)
Diabetes Mellitus(Past,Present and Future)
 
Anti diabetic drugs
Anti diabetic drugsAnti diabetic drugs
Anti diabetic drugs
 
Endocrine pancreas
Endocrine pancreasEndocrine pancreas
Endocrine pancreas
 
Pharmacology of antidiabetic drugs
Pharmacology of antidiabetic drugsPharmacology of antidiabetic drugs
Pharmacology of antidiabetic drugs
 
Endocrine main [Autosaved].pptx for students
Endocrine main [Autosaved].pptx for studentsEndocrine main [Autosaved].pptx for students
Endocrine main [Autosaved].pptx for students
 
diabetes mellitus
 diabetes mellitus diabetes mellitus
diabetes mellitus
 
Anti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptxAnti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptx
 

Recently uploaded

Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...RKavithamani
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991RKavithamani
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxRoyAbrique
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 

Recently uploaded (20)

INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 

SHADY-Insulin-Hormone.pdf

  • 1. INSULIN: STRUCTURE, SYNTHESIS AND ANALYTICAL METHODS Prepared By :- SHADY ALHUSSAYNI SBCB (R1)
  • 2. OUTLINE: • Insulin structure, synthesis and regulation. • Biochemical and physiological effects of Insulin. • Review of analytical methods. • Associated diseases at variety level of insulin.
  • 3. INTRODUCTION: -It is a peptide hormone produced by beta cells of Langerhans of pancreas. -It is the main anabolic hormone of the body. -It regulates the metabolism of carbohydrates, fats and protein by promoting the absorption of glucose from the blood into fat in liver and skeletal muscle cells.
  • 4. INTRODUCTION: -It was the first hormone to be isolated, purified & synthesized. -First hormone to be sequenced. -First hormone to be produced by recombinant DNA technology.
  • 5. STRUCTURE: • Human Insulin contain 51 aminoacids, arranged in TWO Polypeptide chains. • Chain A = 21 AA • Chain B = 30 AA • Two Interchain Disulfide bridge = A7-B7 & A20-B19. • Intrachain Disulfide link in chain A = 6-11.
  • 7. SYNTHESIS AND REGULATION: • The preproinsulin precursor of insulin is encoded by the INS gene. • Gene is located on Chr 11. • Produced from β-cell of Langerhans of pancreas. • Synthesis involve two precursors :- 1. Preproinsulin = 108AA 2. Proinsulin = 86 AA
  • 8. SYNTHESIS AND REGULATION: • These are serially degraded to form the active hormone Insulin and Connecting peptide (C-Peptide). • C-peptide has no biological activity, however its estimation in plasma serves as the useful index for endogenous production of insulin. • In β-cells, Insulin combines with Zinc to form a complex & stored in granules.
  • 9. REGULATION OF INSULIN SECRETION • About 40-50Units secreted daily by Human pancreas. • Normal value is = 20-30 μU/ml.
  • 10. BIOCHEMICAL AND PHYSIOLOGICAL EFFECTS: (1) Carbohydrate metabolism: (a) It increases the rate of transport of glucose across the cell membrane in adipose tissue and muscle. (b) it increases the rate of glycolysis in muscle and adipose tissue. (c) it stimulates the rate of glycogen synthesis in several tissues. It also decreases the rate of glycogen breakdown in muscle and liver. (d) it inhibits the rate of gluconeogenesis in the liver.
  • 11. (2) Lipid Metabolism: (a) It decreases the rate of lipolysis in adipose tissue and hence lowers the plasma fatty acid level (b) it stimulates fatty acid and triacylglycerol synthesis in tissues. (c) it increases the rate of very-low-density lipoprotein formation in the liver. (d) it increases the uptake of triglyceride from the blood into adipose tissue and muscle. (e) it decreases the rate of fatty acid oxidation in muscle and liver (f) it increases the rate of cholesterol synthesis in liver.
  • 12. (3) Protein Metabolism: (a) It increases the rate of transport of some amino acids into tissues, (b) it increases the rate of protein synthesis in muscle, adipose tissue, liver, and other tissues. (c) it decreases the rate of protein degradation in muscle (and perhaps other tissues) (d) it decreases the rate of urea formation.
  • 13.
  • 14. Review of Analytical Methods. • Nowadays, immunoassays and chromatographic assays are the primary methods that have been developed for insulin analysis. • Generally, immunoassays including: • Enzyme-linked immunosorbent assay (ELISA). • Chemiluminescence immunoassay (CLIA). • Radioimmunoassay (RIA). ((good selectivity towards insulin with less interferences))
  • 15. Review of Analytical Methods. • Chromatographic assays including: • High performance liquid chromatography coupled with ultraviolet detection (HPLC-UV). • Liquid chromatography with tandem mass spectrometry (LC-MS/MS). ((are highly sensitive and capable of simultaneous detection of insulin)).
  • 16. VARIATION IN THE LEVEL OF INSULIN SECRETION AND ASSOCIATED DISEASES • High level of insulin: 1-Acromegaly 2-Cushing syndrome 3-Fructose or galactose intolerance 4-Insulinomas – a tumor of beta cells producing excess insulin. 5-Obesity 6-Insulin resistance, such as appears in type 2 diabetes and metabolic syndrome
  • 17. VARIATION INTHE LEVEL OF INSULIN SECRETION AND ASSOCIATED DISEASES • Low level of insulin: 1-Diabetes 2-Hypopituitarism 3-Pancreatic diseases such as chronic pancreatitis (including cystic fibrosis) and pancreatic cancer.
  • 18. DISEASE ASSOCIATEDWITH HIGH INSULIN LEVEL • Insulinoma :- Insulinoma is a tumor found in the pancreas that continues to produce insulin even when your blood sugar drops too low. • High blood insulin levels cause low blood sugar levels called Hypoglycemia. • Hypoglycemia may be mild, leading to symptoms such as anxiety and hunger or it can be severe, leading to seizures, coma and even death.
  • 19. SYMPTOMS OF INSULINOMA • Anxiety • Weight Gain (patient can become excessively obese) • Behavior Changes • CloudedVision • Confusion • Hunger • Loss of Consciousness • Rapid Heart Rate • Sweating
  • 20. TESTS FOR INSULINOMA DIAGNOSIS • After fasting, blood tested for: • C-peptide level. • Glucose level. • Insulin level. • Drugs that cause the pancreas to release insulin. • CT or MRI scan of the abdomen may be done to look for a tumor in the pancreas.
  • 21. DISEASE ASSOCIATEDWITH LOW INSULIN LEVEL • Diabetes mellitus (DM):- • Commonly known as diabetes, is a group of metabolic disorders characterized by high blood sugar levels over a prolonged period. Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. • Type 1 diabetes results from the pancreas's failure to produce enough insulin due to loss of beta cells.This form was previously referred to as "insulin-dependent diabetes mellitus" • Type 2 diabetes begins with insulin resistance, a condition in which cells fail to respond to insulin properly.As the disease progresses, a lack of insulin may also develop.This form was previously referred to as "non-insulin-dependent diabetes mellitus"
  • 23. DIAGNOSIS OF DIABETES • Analysis for the Diagnosis & Monitoring of the Diabetes status:- • Blood Glucose (Fasting & PPBS). • OGTT (Oral Glucose tolerance test). • Glycated Hb (HbA1c). • Urine Glucose. • Insulin, C-Peptide.
  • 24. INSULIN RESISTANCE (IR) • Insulin resistance (IR) is a pathological condition in which cells fail to respond normally to the insulin. • Tests For insulin resistance:- • Hyperinsulinemic euglycemic clamp (Gold std). • Modified insulin suppression test. • HOMA (homeostatic model assessment), QUICKI (quantitative insulin sensitivity check index).